Tolerability of fibric acids. comparative data and biochemical bases
- 30 November 1992
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 26 (3) , 243-260
- https://doi.org/10.1016/1043-6618(92)90212-t
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Dissociation of hypolipidemic and antiplatelet actions from adverse myotonic effects of clofibric acid related enantiomersJournal of Medicinal Chemistry, 1987
- Effect of ciprofibrate treatment on biliary lipids in patients with hyperlipoproteinaemiaEuropean Journal of Clinical Investigation, 1984
- 20,25-Diazacholesterol, clofibric acid and 2,4-dichlorophenoxyacetic acid— All inducers of myotonia—Perturb the post-lanosterol sector of sterol biosynthesis in cultured chick embryo fibroblastsBiochemical and Biophysical Research Communications, 1980
- Cholesterol Crystals and the Formation of Cholesterol GallstonesNew England Journal of Medicine, 1980
- Clofibrate-induced myotonia in the ratCellular and Molecular Life Sciences, 1978
- Risk Factors for the Development of Cholelithiasis in ManNew England Journal of Medicine, 1978
- Effects of clofibrate and sulfinpyrazone on platelet survival time in coronary artery disease.Circulation, 1975
- Clofibrate Reversal of Platelet Hypersensitivity in HyperbetalipoproteinemiaCirculation, 1974